Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CASPOFUNGIN Cause Disease progression? 67 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 67 reports of Disease progression have been filed in association with CASPOFUNGIN (CASPOFUNGIN ACETATE). This represents 1.8% of all adverse event reports for CASPOFUNGIN.

67
Reports of Disease progression with CASPOFUNGIN
1.8%
of all CASPOFUNGIN reports
19
Deaths
46
Hospitalizations

How Dangerous Is Disease progression From CASPOFUNGIN?

Of the 67 reports, 19 (28.4%) resulted in death, 46 (68.7%) required hospitalization, and 3 (4.5%) were considered life-threatening.

Is Disease progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CASPOFUNGIN. However, 67 reports have been filed with the FAERS database.

What Other Side Effects Does CASPOFUNGIN Cause?

Drug ineffective (1,060) Off label use (325) Product use in unapproved indication (257) Multiple organ dysfunction syndrome (215) Drug resistance (194) Septic shock (165) Aspergillus infection (154) Drug reaction with eosinophilia and systemic symptoms (136) Systemic mycosis (129) Pyrexia (128)

What Other Drugs Cause Disease progression?

RITUXIMAB (7,282) CYCLOPHOSPHAMIDE (7,100) DOXORUBICIN (6,165) VINCRISTINE (5,252) PREDNISONE (5,096) BEVACIZUMAB (4,653) DEXAMETHASONE (4,545) CARBOPLATIN (4,538) CAPECITABINE (3,808) ETOPOSIDE (3,776)

Which CASPOFUNGIN Alternatives Have Lower Disease progression Risk?

CASPOFUNGIN vs CATEQUENTINIB CASPOFUNGIN vs CC-4047 CASPOFUNGIN vs CEDAZURIDINE\DECITABINE CASPOFUNGIN vs CEDIRANIB CASPOFUNGIN vs CEFACLOR

Related Pages

CASPOFUNGIN Full Profile All Disease progression Reports All Drugs Causing Disease progression CASPOFUNGIN Demographics